Tiziana doses first three patients in ALS trial of nasal antibody foralumab1 report from 1 outlet in 1 language · first reported 2026-09-28 13:14 UTC · updated 2026-09-28 13:14 UTC · JSONHealthamyotrophic lateral sclerosisReportsTiziana doses first three patients in ALS trial of nasal antibody foralumabproactiveinvestors.com · en · 2026-09-28 13:14 UTC